MA33027B1 - Nouveau procede de synthese de l'ivabradine zet de ses sels d'addition a un acide pharmaceutiquement acceptable - Google Patents

Nouveau procede de synthese de l'ivabradine zet de ses sels d'addition a un acide pharmaceutiquement acceptable

Info

Publication number
MA33027B1
MA33027B1 MA34066A MA34066A MA33027B1 MA 33027 B1 MA33027 B1 MA 33027B1 MA 34066 A MA34066 A MA 34066A MA 34066 A MA34066 A MA 34066A MA 33027 B1 MA33027 B1 MA 33027B1
Authority
MA
Morocco
Prior art keywords
pharmaceutically acceptable
ivabradine
acceptable acid
salts
zeta
Prior art date
Application number
MA34066A
Other languages
Arabic (ar)
English (en)
Inventor
Jean-Louis Peglion
AIMéE DESSINGES
Bernard Serkiz
Jean-Michel Lerestif
Jean-Pierre Lecouve
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of MA33027B1 publication Critical patent/MA33027B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Procédé de synthèse de l'ivabradine de formule (I) et de ses sels d'addition à un acide pharmaceutiquement acceptable.
MA34066A 2009-02-04 2010-02-03 Nouveau procede de synthese de l'ivabradine zet de ses sels d'addition a un acide pharmaceutiquement acceptable MA33027B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0900457A FR2941695B1 (fr) 2009-02-04 2009-02-04 Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
PCT/FR2010/000080 WO2010089475A1 (fr) 2009-02-04 2010-02-03 Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable

Publications (1)

Publication Number Publication Date
MA33027B1 true MA33027B1 (fr) 2012-02-01

Family

ID=40800462

Family Applications (1)

Application Number Title Priority Date Filing Date
MA34066A MA33027B1 (fr) 2009-02-04 2010-02-03 Nouveau procede de synthese de l'ivabradine zet de ses sels d'addition a un acide pharmaceutiquement acceptable

Country Status (20)

Country Link
US (1) US8415468B2 (fr)
EP (1) EP2393784A1 (fr)
JP (1) JP5563600B2 (fr)
KR (1) KR20110112467A (fr)
CN (1) CN102300849A (fr)
AR (1) AR075227A1 (fr)
AU (1) AU2010210054B2 (fr)
BR (1) BRPI1008841A2 (fr)
CA (1) CA2750089C (fr)
EA (1) EA019465B1 (fr)
FR (1) FR2941695B1 (fr)
GE (1) GEP20135960B (fr)
MA (1) MA33027B1 (fr)
MX (1) MX2011007978A (fr)
MY (1) MY156630A (fr)
NZ (1) NZ594087A (fr)
SG (1) SG172913A1 (fr)
UA (1) UA101091C2 (fr)
WO (1) WO2010089475A1 (fr)
ZA (1) ZA201105172B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2473544C2 (ru) 2007-05-30 2013-01-27 Инд-Свифт Лабораториз Лимитед Способ получения ивабрадина гидрохлорида и его полиморфных модификаций
FR2971507B1 (fr) * 2011-02-14 2013-01-18 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2984319B1 (fr) * 2011-12-20 2013-12-27 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2984320B1 (fr) * 2011-12-20 2013-11-29 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2988720B1 (fr) * 2012-03-27 2014-03-14 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
CN103848789B (zh) * 2012-11-29 2016-05-18 江苏恒瑞医药股份有限公司 一种伊伐布雷定的制备方法
FR3003859B1 (fr) * 2013-03-26 2015-03-13 Servier Lab "procede de synthese de derives de la 7,8-dimethoxy-1,3-dihydro-2h-3-benzazepin-2-one et application a la synthese de l'ivabradine"
EP3101010A1 (fr) 2015-06-03 2016-12-07 Urquima S.A. Nouvelle méthode de préparation de la base de l'ivabradine avec une haute pureté et de ses sels
US10177698B1 (en) 2017-11-06 2019-01-08 The Boeing Company Counter-field winding in electrical generator
CN113372274B (zh) * 2020-03-10 2023-03-24 鲁南制药集团股份有限公司 一种伊伐布雷定的制备方法
CN113372273B (zh) * 2020-03-10 2023-05-09 鲁南制药集团股份有限公司 一种伊伐布雷定中间体化合物iv

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3119874A1 (de) * 1981-05-19 1982-12-09 Dr. Karl Thomae Gmbh, 7950 Biberach "benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel"
DE3640641A1 (de) * 1986-11-28 1988-07-14 Thomae Gmbh Dr K Neue heteroaromatische aminderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
FR2671350A1 (fr) * 1991-01-08 1992-07-10 Adir Nouveaux derives de benzisoxazole et de benzisothiazole, leur procede de preparation, et les compositions pharmaceutiques les renfermant.
FR2681862B1 (fr) * 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
FR2868777B1 (fr) * 2004-04-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
ES2381771T3 (es) * 2006-11-30 2012-05-31 Cadila Healthcare Limited Procedimiento para la preparación de hidrocloruro de ivabradina
WO2008125006A1 (fr) * 2007-04-12 2008-10-23 Utopharm (Shanghai) Co., Ltd Procédés de préparation du chlorhydrate d'ivabradine et de sa forme cristalline stable

Also Published As

Publication number Publication date
FR2941695A1 (fr) 2010-08-06
EA201101147A1 (ru) 2012-03-30
CN102300849A (zh) 2011-12-28
AU2010210054A1 (en) 2011-08-04
WO2010089475A1 (fr) 2010-08-12
AR075227A1 (es) 2011-03-16
BRPI1008841A2 (pt) 2020-05-26
CA2750089C (fr) 2013-10-08
SG172913A1 (en) 2011-08-29
EP2393784A1 (fr) 2011-12-14
JP5563600B2 (ja) 2014-07-30
EA019465B1 (ru) 2014-03-31
NZ594087A (en) 2013-03-28
UA101091C2 (ru) 2013-02-25
KR20110112467A (ko) 2011-10-12
MX2011007978A (es) 2011-08-15
MY156630A (en) 2016-03-15
CA2750089A1 (fr) 2010-08-12
JP2012516880A (ja) 2012-07-26
GEP20135960B (en) 2013-11-11
ZA201105172B (en) 2012-09-26
US8415468B2 (en) 2013-04-09
AU2010210054B2 (en) 2012-03-22
FR2941695B1 (fr) 2011-02-18
US20110294999A1 (en) 2011-12-01

Similar Documents

Publication Publication Date Title
MA33027B1 (fr) Nouveau procede de synthese de l'ivabradine zet de ses sels d'addition a un acide pharmaceutiquement acceptable
MA31498B1 (fr) Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2868777A1 (fr) Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
MA31746B1 (fr) Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
NZ598277A (en) Process for preparing azabicyclic compounds
MA33580B1 (fr) Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
MX340573B (es) Proceso para la fabricacion de compuestos farmaceuticamente activos.
FR2932800B1 (fr) Nouveau procede de synthese de la 7,8-dimethoxy-1,3-dihydro- 2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
MA34990B1 (fr) Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
MA31745B1 (fr) Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
MA32681B1 (fr) Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
IL200323A0 (en) Synthesis of glyt-1 inhibitors
FR2984319B1 (fr) Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2999178B1 (fr) Nouveau procede de synthese du 3-(2-bromo-4,5-dimethoxyphenyl)propanenitrile, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
MA35597B1 (fr) Nouveau procédé de synthése du 3-(2-bromo-4,5-dimethoxyphezyl) propanenitrile et application a la synthese de l'ivabradine et de ses sels d"addition a u acide pharmaceutiquemebnt acceptable
MA34584B1 (fr) Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2984320B1 (fr) Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
TH110601B (th) กระบวนการแบบใหม่สำหรับการสังเคราะห์ของไอวาบราดีน และเกลือของการเติมของสิ่งนี้ด้วยกรดที่ยอมรับได้ทางเภสัชกรรม
SG165255A1 (en) New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid